Sermorelin Acetate in the Treatment of Age-Related Growth Hormone Deficiency: A Randomized Controlled Trial
Katz LE, Pemberton JL, Sims EE, et al.
Aging Clinical and Experimental Research, 2003 · n = 89
Key finding
Sermorelin increased serum IGF-1 by mean 156 ng/mL (baseline 96 ng/mL) with improved physical function scores (p<0.001).
Summary
Double-blind trial evaluating sermorelin in older adults (>60 years) with documented low IGF-1 levels.
Read the study
The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.
View on PubMedRelated compound
More research on Sermorelin
Sermorelin Acetate Administration Increases Mean Plasma GH Levels and Reduces Waist Circumference in Obese Men
Journal of Clinical Endocrinology & Metabolism · 2005 · Human RCT
Sermorelin Stimulates Growth Hormone Secretion in Older Adults Independent of Body Mass Index
Metabolism · 2004 · Human Pilot
Sermorelin Improves Insulin Secretion and Glucose Tolerance in Older Subjects with Impaired Fasting Glucose
Journal of Clinical Endocrinology & Metabolism · 2002 · Human RCT
Sermorelin Restores Bone Mineral Density in Growth Hormone-Deficient Adults: A 2-Year Randomized Trial
Journal of Clinical Endocrinology & Metabolism · 2002 · Human RCT
GHRH Analog Sermorelin Effects on Body Composition, Lipolysis, and Metabolic Parameters in Older Men
Journal of Gerontology: Biological Sciences · 2001 · Human RCT